GlassScriptPhysician profile
Floyd L Barry
NPI 1649257429
$1,845.14
in general payments reported to CMS, 2019-2025
18 companies · $334 in 2025
The $334 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $181 · 2021: $321 · 2022: $327 · 2023: $304 · 2024: $214 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $265.11 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $217.40 | 2019-2023 | Bexsero, Pediarix, Menveo |
| Ironshore Pharmaceuticals INC. | $187.09 | 2020-2024 | Jornay Pm |
| Novo Nordisk INC | $176.87 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $170.74 | 2020-2025 | |
| Amgen INC. | $164.66 | 2020-2023 | Otezla, Repatha |
| Corium, LLC | $150.24 | 2022-2024 | Azstarys |
| Merck Sharp & Dohme LLC | $136.33 | 2019-2025 | Gardasil 9, M-M-R II, Vaxneuvance |
| Sanofi-Aventis U.S. LLC | $125.81 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $62.97 | 2025 | Jornay Pm |
| Exact Sciences Corporation | $52.12 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $40.04 | 2021-2023 | Vraylar |
| Lilly USA, LLC | $30.03 | 2020 | |
| Tris Pharma INC | $18.94 | 2025 | Dyanavel Xr |
| Nestle Healthcare Nutrition INC. | $14.45 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.23 | 2025 | Airsupra |
| Allergan, INC. | $11.91 | 2020 | |
| Organon LLC | $6.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floyd Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.